Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR4 | Q13639 | 11/20 | 0.35 |
| ▸ | NCF1 | P14598 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2010650 | 0.90 | HTR4 (0.41) | HTR4NCF1ALDH1A1SMN1; SMN2POLB | |
| SCHEMBL8276763 | 0.84 | HTR4 (0.35) | HTR4NCF1ALDH1A1SMN1; SMN2POLB | |
| SCHEMBL3337075 | 0.78 | NCF1 (0.41) | HTR4NCF1CXCR4LMNA | |
| SCHEMBL3337071 | 0.78 | NCF1 (0.41) | HTR4NCF1CXCR4LMNA | |
| SCHEMBL3337067 | 0.78 | NCF1 (0.41) | HTR4NCF1CXCR4LMNA | |
| SCHEMBL5600775 | 0.74 | NCF1 (0.41) | HTR4NCF1CXCR4LMNAGAA | |
| SCHEMBL2966813 | 0.73 | HTR4 (0.42) | HTR4ALDH1A1SMN1; SMN2GAATSHR | |
| SCHEMBL1970098 | 0.73 | PLG (0.35) | HTR4NCF1ALDH1A1CXCR4LMNA | |
| SCHEMBL17693022 | 0.72 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2POLBLMNAGAA | |
| SCHEMBL1809127 | 0.69 | CYP2C19 (0.36) | HTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005092882-A1 | 4-AMINO-5-HALOGENO-BENZAMIDE DERIVATIVES AS 5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL, CNS, NEUROLOGICAL AND CARDIOVASCULAR DISORDERS | PFIZER JAPAN, INC. (JP) | 2005-10-06 | — | — | WO | disclosed |